Minerva Neurosciences Inc (NERV) Triples on Drug Announcement

Volume is exploding on biotech stock Minerva Neurosciences Inc (NASDAQ:NERV) after positive drug trial results

May 26, 2016 at 2:43 PM
facebook X logo linkedin


On Wednesday, biotech stock Minerva Neurosciences Inc (NASDAQ:NERV) hit an all-time low of $3.45 -- unknowingly setting itself up for an astonishing comeback. Specifically, NERV has more than tripled in value today to trade at $11.70, and earlier hit a record high of $12.50. The stock took off after the drug company announced positive trial results for its antidepressant drug candidate -- marking a rare bit of good news for biotech stocks

The biotech stock's trading volume has crushed previous intraday highs following the drug data. In fact, the stock is easily the top percentage gainer on the Nasdaq Composite (COMP), and it's also one of the most traded, with today's volume on NERV topping heavyweights such as Microsoft Corporation (NASDAQ:MSFT), Facebook Inc (NASDAQ:FB), and Netflix, Inc. (NASDAQ:NFLX)

The stock hadn't received much attention of any kind from Wall Street before today. For instance, just two analysts have initiated coverage on NERV -- a "strong buy" and "buy," for what it's worth -- and short interest is practically nonexistent, representing just 0.4% of the stock's float. NERV does not have options, either. 

As was mentioned, Minerva Neurosciences Inc (NASDAQ:NERV) had been selling off before today, dropping roughly half its value since its previous May high of $6.98, as of Wednesday's close at $3.54. Looking back even further, shares of NERV had a similar breakout back in early 2015, when the stock surged to an intraday high of $10. However, this success was short lived, as NERV closed that session at $6.49, and spent the rest of the year trading below that level. 

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI